EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 40 / No 1 (March 2008) J Extra Corpor Technol, 40 1 (2008) 27-42 References
Free Access
Issue
J Extra Corpor Technol
Volume 40, Number 1, March 2008
Page(s) 27 - 42
DOI https://doi.org/10.1051/ject/200840027
Published online 15 March 2008
  1. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg. 1997;85:766–82. [CrossRef] [PubMed] [Google Scholar]
  2. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion. 1999;14:269–77. [CrossRef] [PubMed] [Google Scholar]
  3. Menasche P, Edmunds HJr. Extracorporeal circulation: the inflammatory response. In: Cohn LH, Edmunds HJr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hil; 2003;349–360. [Google Scholar]
  4. Wan S, LeClerc J, Vincent J. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676–92. [CrossRef] [PubMed] [Google Scholar]
  5. Marieb EN. Human Anatomy and Physiology, 5th ed. New Jersey: Benjamin Cummings; 2001. [Google Scholar]
  6. Edmunds LHJr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1998;66:S12–6. [CrossRef] [Google Scholar]
  7. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002;82:521–34. [CrossRef] [Google Scholar]
  8. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3–6. [CrossRef] [PubMed] [Google Scholar]
  9. Li S, Price R, Phiroz D, Swan K, Crane TA. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol. 2005;37:180–8. [Google Scholar]
  10. Terumo Cardiovascular Systems, Corp. LeukoGuard-6™ LG Pall leukocyte reduction arterial blood filter for extracorporeal service. 2002 Available online at http://www.terumo-cvs.com/doc/EC47C_LeukoGuardLGBrochure_December2002.pdf Accessed September 12, 2006. [Google Scholar]
  11. Terumo Cardiovascular Systems, Corp. LeukoGuard BC Pall leukocyte reduction blood cardioplegia filter. 2002 Available online at http://www.terumo-cvs.com/doc/EC56D_LeukoGuardBCBrochure_December2002.pdf Accessed September 12, 2006 . [Google Scholar]
  12. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leukocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205–10. [CrossRef] [PubMed] [Google Scholar]
  13. de Vries AJ, Gu YJ, van Oeveren W. The clinical effects and mechanisms of leukocyte depletion filters during cardiac surgery. Ann Card Anesth. 2005;8:117–24. [CrossRef] [PubMed] [Google Scholar]
  14. Thurlow PJ, Doolan L, Sharp R, Sullivan M, Smith B. Studies of the effect of Pall leukocyte filers LG6 and AV6 in an in vitro simulated extracorporeal circulatory system. Perfusion. 1995;10:291–300. [CrossRef] [PubMed] [Google Scholar]
  15. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Filtration of activated granulocytes during cardiopulmonary bypass surgery: a morphological and immunological study to characterize the trapped leukocytes. J Lab Clin Med. 2000;135:238–46. [CrossRef] [Google Scholar]
  16. Aybek T, Kahn MF, Dogan S, et al. Cardiopulmonary bypass impairs left ventricular function determined by conductance catheter measurement. Thorac Cardiovasc Surg. 2003;51:301–5. [CrossRef] [PubMed] [Google Scholar]
  17. Gorcsan J3rd, Gasior TA, Mandarino WA, Deneault DG, Hattler BG, Pinsky MR. Assessment of the immediate effects of cardiopulmonary bypass of left ventricular perfuomance by on-line pressure area relations. Circulation. 1994;89:180–90. [CrossRef] [PubMed] [Google Scholar]
  18. Khuri SF, Axford TC, Garcia JP, et al. Metabolic correlates of myocardial stunning and the effect of cardiopulmonary bypass. J Card Surg. 1993;8(Suppl 2):262–70. [CrossRef] [Google Scholar]
  19. Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg. 2001;71:1491–5. [CrossRef] [Google Scholar]
  20. Matheis G, Scholz M, Gerber J, Abdel-Rahman U, WimmerGreinecker G, Moritz A. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43–9. [CrossRef] [PubMed] [Google Scholar]
  21. Di Salvo C, Louca LL, Pattichis K, Hooper J, Walesby RK. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report. J Cardiovasc Surg (Torino). 1996;37(Suppl 1):93–100. [PubMed] [Google Scholar]
  22. Whitaker DC, Stygall J, Harrison MJ, et al. Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. Perfusion. 2006;21:55–60. [CrossRef] [PubMed] [Google Scholar]
  23. Leal-Noval SR, Amaya R, Herruzo A, et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg. 2005;80:1394–400. [CrossRef] [Google Scholar]
  24. Sahlman A, Ahonen J, Salo JA, Ramo OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand. 2001;45:558–63. [CrossRef] [Google Scholar]
  25. Heggie AJ, Corder JS, Crichton PR, et al. Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1). Perfusion. 1998;13:17–25. [CrossRef] [PubMed] [Google Scholar]
  26. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klovekorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 2000;120:642–50. [CrossRef] [Google Scholar]
  27. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205–10. [CrossRef] [PubMed] [Google Scholar]
  28. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956–061. [CrossRef] [Google Scholar]
  29. Murai N, Imazeki T, Shioguchi S, et al. Leukocyte-depleted continuous blood cardioplegia for coronary artery bypass grafting. Jpn Heart J. 2000;41:425–33. [CrossRef] [PubMed] [Google Scholar]
  30. Sawa Y, Taniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation. 1996;93:1640–6. [CrossRef] [PubMed] [Google Scholar]
  31. Hayashi Y, Sawa Y, Fukuyama N, et al. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J Thorac Cardiovasc Surg. 2003;126:1813–21. [CrossRef] [Google Scholar]
  32. Browning PG, Pullan M, Jackson M, Rashid A. Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion. 1999;14:371–7. [CrossRef] [PubMed] [Google Scholar]
  33. Alexiou C, Tang AT, Sheppard SV, et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomized study. Eur J Cardiothorac Surg. 2004;26:294–300. [CrossRef] [Google Scholar]
  34. Chen Y, Tsai W, Lin C, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:634–43. [CrossRef] [Google Scholar]
  35. Alexiou C, Tang AT, Sheppard SV, et al. A prospective randomized study to evaluate the effect of leukodepletion on the rate of alveolar production of exhaled nitric oxide during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:2139–45. [CrossRef] [Google Scholar]
  36. Sheppard SV, Gibbs RV, Smith DC. Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production? Perfusion. 2004;19:7–10. [CrossRef] [PubMed] [Google Scholar]
  37. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2004;78:1339–44. [CrossRef] [Google Scholar]
  38. Sheppard SV, Gibbs RV, Smith DC. Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indicies in patients with mild lung dysfunction? Br J Anaesth. 2004;93:789–92. [CrossRef] [Google Scholar]
  39. Sutton SW, Patel AN, Chase VA, et al. Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement. Perfusion. 2005;20:21–9. [CrossRef] [PubMed] [Google Scholar]
  40. Mihaljevic T, Tonz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study. J Thorac Cardiovasc Surg. 1995;109:1138–45. [CrossRef] [Google Scholar]
  41. Fabbri A, Manfredi J, Piccin C, et al. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16(Suppl):11–8. [CrossRef] [PubMed] [Google Scholar]
  42. Tang ATM, Alexiou C, Hsu J, et al. Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg. 2002;74:372–7. [CrossRef] [Google Scholar]
  43. Whitaker DC, Newman SP, Stygall J, Hope-Wynne C, Harrison MJ, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2004;25:267–74. [CrossRef] [Google Scholar]
  44. Chen Y, Tsai W, Lin C, et al. Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg. 2002;123:218–24. [CrossRef] [Google Scholar]
  45. Stefanou DC, Gourlay T, Asimakopoulos G, Taylor KM. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion. 2001;16:51–8. [CrossRef] [PubMed] [Google Scholar]
  46. Mair P, Hoermann C, Mair J, Margreiter J, Puschendorf B, Balogh D. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery. Acta Anaesthesiol Scand. 1999;43:452–7. [CrossRef] [Google Scholar]
  47. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S, Repo H. Activation of neutrophils and monocytes b a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;129:851–9. [CrossRef] [Google Scholar]
  48. Baksaas ST, Flom-Halvorsen HI, Ovrum E, Mollnes TE, Brosstad F, Svennevig JL. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14:107–17. [CrossRef] [PubMed] [Google Scholar]
  49. Salamonsen RF, Anderson J, Anderson M, Bailey M, Magrin G, Rosenfeldt F. Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg. 2005;79:2032–9. [CrossRef] [Google Scholar]
  50. Samankatiwat P, Samartzis I, Lertsithichai P, et al. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion. 2003;18:95–105. [CrossRef] [PubMed] [Google Scholar]
  51. Gu YJ, de Vries AJ, Vos P, Boonstra PW, van Oeveren W. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann Thorac Surg. 1999;67:604–9. [CrossRef] [Google Scholar]
  52. de Vries AJ, Gu YJ, Post WJ, et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion. 2003;18:31–8. [CrossRef] [PubMed] [Google Scholar]
  53. Olivencia-Yurvati AH, Wallace WE, Wallace N, et al. Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation. Perfusion. 2002;17:35–9. [CrossRef] [PubMed] [Google Scholar]
  54. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status postcardiopulmonary bypass. Perfusion. 2003;18:23–31. [CrossRef] [PubMed] [Google Scholar]
  55. Olivencia-Yurvati AH, Wallace N, Ford S, Mallet RT. Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection. Perfusion. 2004;19:S13–9. [CrossRef] [PubMed] [Google Scholar]
  56. Baksaas ST, Videm V, Mollnes TE, et al. Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion. 1998;13:429–36. [CrossRef] [PubMed] [Google Scholar]
  57. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747–54. [CrossRef] [Google Scholar]
  58. Hamada Y, Kawachi K, Nakata T, Kohtani T, Takano S, Tsunooka N. Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery. Artif Organs. 2001;25:1004–8. [CrossRef] [PubMed] [Google Scholar]
  59. Gunaydin S, McCusker K, Vijay V, et al. Clinical significance of strategic leukocyte filtration in different risk cohorts undergoing cardiac surgery. Filtration. 2005;1:95–106. [Google Scholar]
  60. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51:363–8. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.